Cargando…
Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn–AhR–AQP4 signaling pathway
Indoleamine 2,3-dioxygenase 1 (IDO1), indoleamine 2,3-dioxygenase 2 (IDO2), and tryptophan 2,3-dioxygenase (TDO) initiate the first step of the kynurenine pathway (KP), leading to the transformation of l-tryptophan (Trp) into l-kynurenine (Kyn) and other downstream metabolites. Kyn is known as an en...
Autores principales: | Du, Lisha, Xing, Zikang, Tao, Bangbao, Li, Tianqi, Yang, Dan, Li, Weirui, Zheng, Yuanting, Kuang, Chunxiang, Yang, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033114/ https://www.ncbi.nlm.nih.gov/pubmed/32296044 http://dx.doi.org/10.1038/s41392-019-0103-4 |
Ejemplares similares
-
Correction: Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn–AhR–AQP4 signaling pathway
por: Du, Lisha, et al.
Publicado: (2021) -
Amyloid β neurotoxicity is IDO1–Kyn–AhR dependent and blocked by IDO1 inhibitor
por: Duan, Zhenzhen, et al.
Publicado: (2020) -
TDO2 Promotes the EMT of Hepatocellular Carcinoma Through Kyn-AhR Pathway
por: Li, Lei, et al.
Publicado: (2021) -
Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy
por: Shi, Jing, et al.
Publicado: (2019) -
Cancer Associated Fibroblasts Promote Renal Cancer Progression Through a TDO/Kyn/AhR Dependent Signaling Pathway
por: Chen, Li-bo, et al.
Publicado: (2021)